Humanigen Inc (HGENQ)

[$$$eeker]

$KBIO Key Milestones for 2014-2015
2H 2014:
Full enrollment of KB001-A CF Phase 2 study (completed in July 2014)
Q4 2014:
December 2014:
Completion of enrollment in at least one indication in the Phase 2 expansion portion of our KB004 study in hematologic malignancies
KB004 Phase 1 study poster presentation at the American Society of Hematology Annual Meeting
January 2015:
Top line KB001-A CF Phase 2 study results

http://bit.ly/1zJ9bn9